From professional translators, enterprises, web pages and freely available translation repositories.
tseftiofuur
ceftiofur
Last Update: 2017-04-26
Usage Frequency: 8
Quality:
naxcel tseftiofuur
ceftiofur
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
toimeained: tseftiofuur
active substance: ceftiofur
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
tseftiofuur 100 mg/ ml
100 mg / ml
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
tseftiofuur vaba kristallilise tseftiofuurhappena
ceftiofur crystalline free acid corresponding to ceftiofur 100 mg / ml
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
tseftiofuur (vaba kristallilise happena) 200 mg,
ceftiofur (as crystalline free acid) 200 mg,
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
naxcel 100 mg/ml süstesuspensioon sigadele tseftiofuur
naxcel 100 mg/ml suspension for injection for pigs ceftiofur
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
tseftiofuur (vaba kristallilise happena) 200 mg/ml
ceftiofur (as crystalline free acid) 200 mg/ml.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
pärast manustamist metaboliseerub tseftiofuur kiiresti peamiseks metaboliidiks desfuroüültseftiofuuriks.
after administration, ceftiofur is quickly metabolised to desfuroylceftiofur, the principal active metabolite.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
tseftiofuur inhibeerib bakteri rakuseina sünteesi, omades seega bakteritsiidset toimet.
ceftiofur inhibits the bacterial cell wall synthesis, thereby exerting bactericidal properties.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
määruse (emÜ) nr 2377/90 i lisasse tuleks lisada tseftiofuur.
ceftiofur should be inserted into annex i to regulation (eec) no 2377/90.
Last Update: 2014-11-21
Usage Frequency: 3
Quality:
naxceliga ravi efektiivsust võrreldi tseftiofuur- vesinikkloriidiga ravitud teise veiserühma tulemustega.
the efficacy of the treatment with naxcel was compared with the results seen in another group of cattle that were treated with ceftiofur hydrochloride.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
naxceli toimeaine on tseftiofuur, mis kuulub kolmanda põlvkonna tsefalosporiinideks nimetatavate antibiootikumide rühma.
the active substance in naxcel is ceftiofur, which belongs to a class of antibiotics called “third generation cephalosporins”.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
tseftiofuur (vaba kristallilise happena) 200 mg/ml, Õlikandja (taimeõli)
ceftiofur (as crystalline free acid) 200 mg/ml oily vehicle (vegetable origin).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kõik tsefalosporiiniantibiootikumid, sealhulgas tseftiofuur, hävitavad baktereid sel teel, et takistavad bakteriraku membraani moodustamist.
all these cephalosporin antibiotics, including ceftiofur, kill bacteria by disrupting the building of the bacterial cell walls.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
tseftiofuur on kolmanda põlvkonna tsefalosporiinantibiootikum, mis toimib aktiivselt gram- negatiivsete ja gram-positiivsete patogeenide vastu.
ceftiofur is a third generation cephalosporin antibiotic, which is active against many gram-positive and gram-negative pathogens.
penitsilliinid ja tsefalosporiinid, nagu tseftiofuur, võivad inimestel ja loomadel süstimisel, sissehingamisel, allaneelamisel või kontaktil nahaga põhjustada ülitundlikkust.
penicillins and cephalosporins such as ceftiofur may cause hypersensitivity in people and in animals following injection, inhalation, ingestion or skin contact.
tseftiofuur (nagu ka teised tsefalosporiinid ja penitsilliinid) võib inimestel või loomadel põhjustada allergilist reaktsiooni, mis võib mõnikord olla raske.
ceftiofur (like other cephalosporins or penicillins) may cause allergic reaction in humans or in animals, which may occasionally be serious.
teadusuuringute lõpuleviimiseks tuleks tseftiofuur, danofloksatsiin ja netobimiin lisada määruse (emÜ) nr 2377/90 iii lisasse;
whereas, in order to allow for the completion of scientific studies, ceftiofur, danofloxacin and netobimin should be inserted into annex iii to regulation (eec) no 2377/90;